Francesco Giaroni

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Eddie B. S. Tan, Nishit P. Parikh, Rajan K. Patel, 2023, The Lancet.

Similar Rates of AKI during the First Two Waves of COVID-19 in Northern Italy: a single-center study

R. Magistroni, J. Milic, M. Meschiari, 2021, medRxiv.

Ultrasound-assessed diaphragmatic impairment is a predictor of outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease undergoing noninvasive ventilation

E. Clini, S. Cerri, A. Marchioni, 2018, Critical Care.

Incidence of nephrogenic systemic fibrosis after administration of gadoteric acid in patients on renal replacement treatment.

G. Cappelli, P. Torricelli, G. Alfano, 2020, Magnetic resonance imaging.

Acid base disorders in patients with COVID-19

M. Girardis, A. Iannone, R. Magistroni, 2021, International Urology and Nephrology.

Automated Prediction of Kidney Failure in IgA Nephropathy with Deep Learning from Biopsy Images

E. Mancini, C. Grana, L. Gesualdo, 2022, Clinical journal of the American Society of Nephrology : CJASN.

Serial ultrasound assessment of diaphragmatic function and clinical outcome in patients with amyotrophic lateral sclerosis

E. Clini, S. Cerri, J. Mandrioli, 2019, BMC Pulmonary Medicine.

Rituximab in people living with HIV affected by immune-mediated renal diseases: a case-series

C. Mussini, G. Guaraldi, G. Mosconi, 2020, International journal of STD & AIDS.

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

N. Perico, M. Jardine, V. Perkovic, 2023, The Lancet.